Were Analysts Bullish Chiasma, Inc. (NASDAQ:CHMA) This Week?

March 14, 2018 - By Michael Collier

 Were Analysts Bullish Chiasma, Inc. (NASDAQ:CHMA) This Week?

Chiasma, Inc. (NASDAQ:CHMA) Ratings Coverage

Among 3 analysts covering Chiasma (NASDAQ:CHMA), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Chiasma had 6 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Barclays Capital given on Monday, April 25. The company was initiated on Monday, August 10 by Cowen & Co. The rating was downgraded by Barclays Capital on Tuesday, January 17 to “Underweight”. On Monday, April 18 the stock rating was downgraded by William Blair to “Market Perform”. On Monday, August 10 the stock rating was initiated by Barclays Capital with “Overweight”. The stock has “Outperform” rating by William Blair on Monday, August 10. Below is a list of Chiasma, Inc. (NASDAQ:CHMA) latest ratings and price target changes.

The stock decreased 1.59% or $0.03 during the last trading session, reaching $1.55. About 12,347 shares traded. Chiasma, Inc. (NASDAQ:CHMA) has declined 48.76% since March 14, 2017 and is downtrending. It has underperformed by 65.46% the S&P500.

Chiasma, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies using transient permeability enhancer technology platform. The company has market cap of $37.79 million. The firm offers octreotide capsules, which is in Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodyÂ’s production of excess growth hormone under the MYCAPSSA name. It currently has negative earnings.

More notable recent Chiasma, Inc. (NASDAQ:CHMA) news were published by: Marketwatch.com which released: “Chiasma Inc.” on April 03, 2016, also Globenewswire.com with their article: “Chiasma to Present at the Cowen and Company 38th Annual Health Care Conference” published on February 28, 2018, Globenewswire.com published: “Chiasma Announces Corporate Restructuring Plan and Provides Regulatory Update …” on June 14, 2016. More interesting news about Chiasma, Inc. (NASDAQ:CHMA) were released by: Quotes.Wsj.com and their article: “Chiasma Inc. CHMA (US: Nasdaq)” published on July 10, 2015 as well as Globenewswire.com‘s news article titled: “Chiasma Honors Patients, Researchers for Rare Disease Day 2018” with publication date: February 28, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.